wxfl10030390
Small moleculeexperimental
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Oct 25, 2018 (NCT03730142)
Timeline
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06124963 | Phase 2 | Aug 25, 2023 | Shanghai Jiatan Pharmatech Co., Ltd |
| NCT06117566 | Phase 1/Phase 2 (Phase 2) | Nov 18, 2022 | Jilin University, Shanghai Jiatan Pharmatech Co., Ltd |
| NCT06132932 | Phase 1/Phase 2 (Phase 2) | Jun 3, 2021 | Huazhong University of Science and Technology, Shanghai Jiatan Pharmatech Co., Ltd |
| NCT06117540 | Phase 2 | May 11, 2021 | Fudan University, Shanghai Jiatan Pharmatech Co., Ltd |
| NCT03730142 | Phase 1 | Oct 25, 2018 | Huazhong University of Science and Technology, Shanghai Jiatan Pharmatech Co., Ltd |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Shanghai Jiatan Pharmatech Co., Ltd | Government | 5 | 5 | 2 | 2018 |
| Huazhong University of Science and Technology | Academic/Hospital | 2 | 0 | 2 | 2018 |
| Fudan University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Jilin University | Academic/Hospital | 1 | 0 | 1 | 2022 |
4 organizations
Page 1 / 1